SIE

209.2

-0.19%↓

AIR.FR

164.7

-0.6%↓

ENR.DE

150.5

+1.93%↑

RHM

1,458

-1.22%↓

HO

240.3

+0.29%↑

SIE

209.2

-0.19%↓

AIR.FR

164.7

-0.6%↓

ENR.DE

150.5

+1.93%↑

RHM

1,458

-1.22%↓

HO

240.3

+0.29%↑

SIE

209.2

-0.19%↓

AIR.FR

164.7

-0.6%↓

ENR.DE

150.5

+1.93%↑

RHM

1,458

-1.22%↓

HO

240.3

+0.29%↑

SIE

209.2

-0.19%↓

AIR.FR

164.7

-0.6%↓

ENR.DE

150.5

+1.93%↑

RHM

1,458

-1.22%↓

HO

240.3

+0.29%↑

SIE

209.2

-0.19%↓

AIR.FR

164.7

-0.6%↓

ENR.DE

150.5

+1.93%↑

RHM

1,458

-1.22%↓

HO

240.3

+0.29%↑

Search

Ayvens SA

Gesloten

SectorIndustrieën

9.865 -0.2

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

9.725

Max

9.91

Belangrijke statistieken

By Trading Economics

Inkomsten

-259M

232M

Verkoop

-36M

13B

K/W

Sectorgemiddelde

8.689

61.065

EPS

0.28

Dividendrendement

6.18

Winstmarge

1.843

Werknemers

13,000

EBITDA

155M

1.9B

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+30.11% upside

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

6.18%

2.23%

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-2.2B

7.6B

Vorige openingsprijs

10.07

Vorige sluitingsprijs

9.865

Nieuwssentiment

By Acuity

21%

79%

52 / 406 Rangschikking in Industrials

Ayvens SA Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

23 mrt 2026, 23:47 UTC

Acquisities, Fusies, Overnames

Gilead Sciences to Buy Ouro Medicines, Collaborate With Galapagos on Purchased Assets -- Update

23 mrt 2026, 22:55 UTC

Acquisities, Fusies, Overnames

Gilead Sciences to Buy Ouro Medicines for Up to $2.18 Billion

23 mrt 2026, 21:51 UTC

Acquisities, Fusies, Overnames

Italy's Postal Service Makes $12.50 Billion Bid for Telecom Italia -- 3rd Update

23 mrt 2026, 23:59 UTC

Marktinformatie

Global Equities Roundup: Market Talk

23 mrt 2026, 23:59 UTC

Marktinformatie

Woodside, Santos Earnings Power Up on Surging LNG Prices -- Market Talk

23 mrt 2026, 23:50 UTC

Marktinformatie

Nikkei May Rise on Hopes for U.S. Talks With Iran -- Market Talk

23 mrt 2026, 23:37 UTC

Marktinformatie

Gold Rises, Boosted by Fall in Dollar, U.S. Treasury Yields -- Market Talk

23 mrt 2026, 22:42 UTC

Marktinformatie
Belangrijke Nieuwsgebeurtenissen

Global Equities Roundup: Market Talk

23 mrt 2026, 22:42 UTC

Marktinformatie
Belangrijke Nieuwsgebeurtenissen

Bell Potter Names Miners Less Exposed to Fuel Price, Supply Risks -- Market Talk

23 mrt 2026, 22:40 UTC

Acquisities, Fusies, Overnames

Gilead Sciences to Buy Ouro Medicines for Up to $2.18B

23 mrt 2026, 22:23 UTC

Marktinformatie

Apollo Debt Solutions Shrugs Off Private-Credit Fears -- Market Talk

23 mrt 2026, 22:22 UTC

Acquisities, Fusies, Overnames

Gilead Sciences: OM336 Is for Treatment of Autoantibodies Driven Immune-Mediated Disease

23 mrt 2026, 22:21 UTC

Acquisities, Fusies, Overnames

Gilead Sciences: Company Would Pay Galapagos Royalties of 20%-23% of Net OM336 Sales

23 mrt 2026, 22:21 UTC

Acquisities, Fusies, Overnames

Gilead Sciences: Company Would Retain Sole Worldwide Commercialization Rights of OM336 Outside of Greater China

23 mrt 2026, 22:20 UTC

Acquisities, Fusies, Overnames

Gilead Sciences: Company, Galapagos Would Collaborate on Development of OM336 >GILD

23 mrt 2026, 22:20 UTC

Acquisities, Fusies, Overnames

Gilead Sciences: Galapagos Would Absorb Substantially All of Ouro's Operating Assets, Retain Its Employees >GILD

23 mrt 2026, 22:19 UTC

Acquisities, Fusies, Overnames

Gilead Sciences: Galapagos Would Pay 50% of Upfront Consideration and 50% of Any Contingent Milestone Payments Payable to Ouro Shareholders

23 mrt 2026, 22:19 UTC

Acquisities, Fusies, Overnames

Gilead Sciences: Currently in Advanced Discussions With Galapagos With Respect to Potential Research-and-Development Collaboration on Acquired Ouro Assets

23 mrt 2026, 22:18 UTC

Acquisities, Fusies, Overnames

Gilead Sciences to Buy Ouro Medicines for About $1.68B Upfront, Up to $500M in Contingent Milestone Payments >GILD

23 mrt 2026, 22:15 UTC

Acquisities, Fusies, Overnames

Gilead Sciences To Acquire Ouro Medicines To Advance First In Class T Cell Engager Program For Autoimmune Diseases >GILD

23 mrt 2026, 22:08 UTC

Marktinformatie

Ebos Needs to Reset Its Gearing Targets -- Market Talk

23 mrt 2026, 21:42 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

23 mrt 2026, 21:42 UTC

Marktinformatie

RBNZ's Breman Strikes Reassuring Tone On Rates -- Market Talk

23 mrt 2026, 21:32 UTC

Winsten

WuXi XDC Cayman: Results Aided by Strong Growth in Contract Research, Development and Manufacturing Organisation Business>2268.HK

23 mrt 2026, 21:32 UTC

Winsten

WuXi XDC Cayman 2025 Net CNY1.56B Vs. Net CNY917.16M >2268.HK

23 mrt 2026, 21:32 UTC

Winsten

WuXi XDC Cayman 2025 Rev CNY5.94B Vs. CNY4.05B >2268.HK

23 mrt 2026, 21:10 UTC

Belangrijke Nieuwsgebeurtenissen

Oil Is Back Under $100. Trump Says Iran Has Agreed to No Nuclear Weapons. -- Barrons.com

23 mrt 2026, 20:50 UTC

Marktinformatie

Tech, Media & Telecom Roundup: Market Talk

23 mrt 2026, 20:50 UTC

Marktinformatie

Health Care Roundup: Market Talk

23 mrt 2026, 20:50 UTC

Marktinformatie
Winsten
Belangrijke Nieuwsgebeurtenissen

Basic Materials Roundup: Market Talk

Peer Vergelijking

Prijswijziging

Ayvens SA Prognose

Koersdoel

By TipRanks

30.11% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 12.53 EUR  30.11%

Hoogste 14.5 EUR

Laagste 11 EUR

Gebaseerd op 3 Wall Street-analisten die 12-maands prijsdoelen bieden voor Ayvens SA - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

3 ratings

1

Buy

2

Hold

0

Sell

Sentiment

By Acuity

52 / 406 Rangschikking in Industrieën

Nieuwssentiment

Zeer Sterk Bearish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Ayvens SA

Ayvens provides service leasing and vehicle fleet management services. Its products and services include full service leasing, fleet management, outsourcing solutions, and sale and lease back; fleet consultancy; and tools and services for fleet managers and drivers. The company is also involved in trading used cars and light commercial vehicles, and the retail sale of vehicles. The company operates in Western Europe, Central and Eastern Europe, Northern Europe, South America, Africa, and Asia. The company was formerly known as ALD S.A. and changed its name to Ayvens in May 2024. The company was incorporated in 1998 and is based in Rueil-Malmaison, France. Ayvens operates as a subsidiary of Société Générale Société anonyme.
help-icon Live chat